These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 11857493)
21. [Expression and significance of fragile histidine triad in oral cancer and precancerous lesions]. Yin C; Shen LJ; Xie SM; Ruan P; Yao X Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):584-6. PubMed ID: 15897145 [TBL] [Abstract][Full Text] [Related]
22. [Loss of exons of FHIT gene and FHIT protein expression in Yunnan tin miners with lung cancer]. Ruan YH; Gao Q; Zhang L; Hua HR; Cheng JL; Jin KW Ai Zheng; 2007 Jun; 26(6):607-12. PubMed ID: 17562266 [TBL] [Abstract][Full Text] [Related]
23. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma. Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140 [TBL] [Abstract][Full Text] [Related]
24. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma]. Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189 [TBL] [Abstract][Full Text] [Related]
25. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas. Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073 [TBL] [Abstract][Full Text] [Related]
26. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines. Simon B; Bartsch D; Barth P; Prasnikar N; Münch K; Blum A; Arnold R; Göke B Cancer Res; 1998 Apr; 58(8):1583-7. PubMed ID: 9563464 [TBL] [Abstract][Full Text] [Related]
27. Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma. Chen PM; Yang MH; Hsiao LT; Yu IT; Chu CJ; Chao TC; Yen CC; Wang WS; Chiou TJ; Liu JH Oncol Rep; 2004 Feb; 11(2):349-56. PubMed ID: 14719066 [TBL] [Abstract][Full Text] [Related]
28. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834 [TBL] [Abstract][Full Text] [Related]
29. Methylation and intratumoural heterogeneity of 14-3-3 sigma in oral cancer. Bhawal UK; Tsukinoki K; Sasahira T; Sato F; Mori Y; Muto N; Sugiyama M; Kuniyasu H Oncol Rep; 2007 Oct; 18(4):817-24. PubMed ID: 17786341 [TBL] [Abstract][Full Text] [Related]
30. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676 [TBL] [Abstract][Full Text] [Related]
31. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328 [TBL] [Abstract][Full Text] [Related]
32. [Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions]. Yin C; Shen LJ; Xie SM; Ruan P; Yao X Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):812-4. PubMed ID: 16027075 [TBL] [Abstract][Full Text] [Related]
33. DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area. Guo XQ; Wang SJ; Zhang LW; Wang XL; Zhang JH; Guo W J Exp Clin Cancer Res; 2007 Dec; 26(4):587-94. PubMed ID: 18365557 [TBL] [Abstract][Full Text] [Related]
34. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis. Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366 [TBL] [Abstract][Full Text] [Related]
35. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation. Hussain A; Gutiérrez MI; Timson G; Siraj AK; Deambrogi C; Al-Rasheed M; Gaidano G; Magrath I; Bhatia K Genes Chromosomes Cancer; 2004 Dec; 41(4):321-9. PubMed ID: 15384174 [TBL] [Abstract][Full Text] [Related]
36. [Association of fragile histidine triad gene (FHIT) with susceptibility to esophageal cancer. A preliminary study]. Li W; Wang X; Cheng G Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):258-60. PubMed ID: 10920977 [TBL] [Abstract][Full Text] [Related]
37. Aberrant FHIT transcripts in human colorectal cancers. Lee SH; Lee SH Res Commun Mol Pathol Pharmacol; 2005; 117-118():153-65. PubMed ID: 18426086 [TBL] [Abstract][Full Text] [Related]
38. Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction. Zhong LP; Zhao SF; Chen GF; Ping FY; Xu ZF; Hu JA Arch Oral Biol; 2006 Dec; 51(12):1112-9. PubMed ID: 16806049 [TBL] [Abstract][Full Text] [Related]
39. [FHIT gene is abnormal in tongue carcinoma cell line]. Liu F; Wu J; Sun Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Sep; 20(3):472-5. PubMed ID: 14565016 [TBL] [Abstract][Full Text] [Related]
40. Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma. Maruyama R; Sugio K; Yoshino I; Maehara Y; Gazdar AF Cancer; 2004 Apr; 100(7):1472-7. PubMed ID: 15042681 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]